The potentially beneficial effects of metformin against cancer are believed to be mediated mainly by 5′-adenosine monophosphate-activated protein kinase (AMPK), a well-conserved energy sensor that plays a key role in the regulation of protein and lipid metabolism in response to changes in fuel availability. This evidence concerns the gene PRKAA1 and cancer.